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Experimental section
General methods: Unless stated otherwise, reactions were performed under a nitrogen atmosphere. Reactions were monitored by thin layer chromatography (TLC) on silica gel plates (60 F254), visualizing with ultraviolet light or iodine spray. Flash chromatography was performed on silica gel (100-200 mesh) using distilled hexane, ethyl acetate, dichloromethane. 1 H NMR and 13 C NMR spectra were determined in CDCl 3 solution on a Varian 400 spectrometer at 400 MHz and 100 MHz, respectively. Proton chemical shifts ( and triethylamine (2.67 mmol) in methanol (5 mL) was stirred at 25-30 °C for 30 min under a nitrogen atmosphere. The acetylenic compound (2) (1.33 mmol) was added, and the mixture was initially stirred at room temperature for 1 h and then at 60-65 °C for 10-12 h. After completion of the reaction, the mixture was cooled to room temperature, diluted with EtOAc (50 mL), and filtered through Celite. The organic solution was washed with water (3 × 30 mL), dried over anhydrous Na 2 SO 4 , and concentrated. The crude residue was purified by column chromatography on silica gel using hexane/ethyl acetate to afford the desired product. 9, 172.2, 168.7, 152.0, 142.2, 139.1, 131.9, 130.6, 129.8, 128.5, 127.3, 121.4, 96.2, 86.9, 25.9, 25.3, 22.5, 22 
2-methyl-4-(5,6,7,8 tetrahydrobenzothieno[2,3-d]pyrimidin-4-yl)but-3-yn-2-ol (3e)
Light brown oil; R f (30% ethyl acetate/n-hexane) 0. 8, 151, 142.8, 138.1, 130.4, 127.2, 106.1, 77.4, 53.4, 29.9, 29.4, 22.7, 22.6, 22.3, 22 
5-methyl-4-(pent-1-ynyl)thieno[2,3-d]pyrimidine (3i)
Light brown oil; R f (25% ethyl acetate/n-hexane) 0. 9, 152.8, 145.0, 130.7, 129.8, 122.5, 100.2, 78.7, 21.7, 21.4, 14.0, 13.7; IR (KBr) 
3-(6,7,8,9)-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-yl)prop-2-yn-1-ol (3j)
Light brown oil; R f (35% ethyl acetate/n-hexane) 0. 7, 151.1, 143.3, 141.4, 132.3, 130.6, 96.6, 82.3, 51.0, 29.9, 28.6, 27.1, 26.7, 26.3; IR (KBr) v max 3230, 3072, 2926 , 2856 , 2228 , 1277 5, 151.6, 143.0, 142.6, 132.7, 130.8, 107.5, 77.4, 32.1 (3C), 30.2, 30.1, 28.4, 27.2, 27.1, 26.5; IR (KBr) 7, 151.4, 143.4, 141.9, 132.5, 130.9, 102.7, 79.5, 65.3, 31.9, 31.0, 30.7, 30.1, 27.3, 27.0, 26.5; IR (KBr) 141.9, 132.2, 130.8, 118.6, 96.4, 80.1, 75.0, 29.7, 27.2, 26.9, 26.8, 26.5, 24.0, 23.8, 18.6 
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Cytotoxicity assay
Some of the compounds synthesized were screened for their cytotoxic activity against chronic myelogenous leukemia (CML). Test compounds were dissolved in DMSO and were diluted appropriately with culture media DMEM (Dulbecco's Modified Eagle's Medium) prior to treatment of cells.
The assay was carried out in a 96 well plate. The cell lines were incubated for 24 h in 100 μL medium. After sufficient growth was observed, different concentrations of the samples were added into each well respectively, with 10% DMSO as a control. After 24 h of incubation the plate was centrifuged and the supernatant was discarded. Then 100 µL of 0.4 mg/mL MTT or tetrazolium salt [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] in PBS (phosphate-buffered saline) was added to the settled cell lines (after centrifugation). After 4 h the plate was again centrifuged and the supernatant was discarded. DMSO and 100 µL of 1:1 DMSO-ethanol were added to the settled cell lines and the plate was measured at OD 595 . The data obtained were used to assess the percentage of cell death.
